Nandana S. Mohanan
Research Subjects
Nandana S. Mohanan has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Nandu K. Mohanan
Post Graduate and Research Department of Chemistry, NSS Hindu College, Changanassery 686102, Kerala, India
1 shared publication - Pradeep Kumar Rajan
Department of Surgery, Joan C. Edwards School of Medicine, Marshall University Huntington, Huntington, WV 25701, USA
1 shared publication - Saumya S. Pillai
Post Graduate and Research Department of Chemistry, NSS Hindu College, Changanassery 686102, Kerala, India
1 shared publication - Sneha S. Pillai
Departments of Surgery, Internal Medicine and Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25701, USA
1 shared publication - Surya Mol Sukumaran
Department of Biotechnology, Mar Thoma College of Science & Technology, Ayur 691534, Kerala, India
1 shared publication - Thaikatt Madhusudhanan Dhanya
Department of Applied Chemistry, Cochin University of Science and Technology, Kochi 22, Kerala, India
1 shared publication
Latest Publications
- Open Access
- 4 August 2025
- Published by MDPI AG in Inorganics
- Vol. 13 (8) , 259
An Insight into the Disease Prognostic Potentials of Nanosensors
Growing interest in the future applications of nanotechnology in medicine has led to groundbreaking developments in nanosensors. Nanosensors are excellent platforms that provide reliable solutions for continuous monitoring and real-time detection of clinical targets. Nanosensors have attracted great attention due to their remarkable sensitivity, portability, selectivity, and automated data acquisition. The exceptional nanoscale properties of nanomaterials used in the nanosensors boost their sensing potential even at minimal concentrations of analytes present in a clinical sample. Along with applications in diverse sectors, the beneficial aspects of nanosensors have been exploited in healthcare systems to utilize their applications in diagnosing, treating, and preventing diseases. Hence, in this review, we have presented an overview of the disease-prognostic applications of nanosensors in chronic diseases through a detailed literature analysis. We focused on the advances in various nanosensors in the field of major diseases such as cancer, cardiovascular diseases, diabetes mellitus, and neurodegenerative diseases along with other prevalent diseases. This review demonstrates various categories of nanosensors with different nanoparticle compositions and detection methods suitable for specific diagnostic applications in clinical settings. The chemical properties of different nanoparticles provide unique characteristics to each nanosensors for their specific applications. This will aid the detection of potential biomarkers or pathological conditions that correlate with the early detection of various diseases. The potential challenges and possible recommendations of the applications of nanosensors for disease diagnosis are also discussed. The consolidated information present in the review will help to better understand the disease-prognostic potentials of nanosensors, which can be utilized to explore new avenues in improved therapeutic interventions and treatment modalities.
- 4 August 2025
- Published by MDPI AG in Inorganics
- Vol. 13 (8) , 259
Open AccessAn Insight into the Disease Prognostic Potentials of Nanosensors
Growing interest in the future applications of nanotechnology in medicine has led to groundbreaking developments in nanosensors. Nanosensors are excellent platforms that provide reliable solutions for continuous monitoring and real-time detection of clinical targets. Nanosensors have attracted great attention due to their remarkable sensitivity, portability, selectivity, and automated data acquisition. The exceptional nanoscale properties of nanomaterials used in the nanosensors boost their sensing potential even at minimal concentrations of analytes present in a clinical sample. Along with applications in diverse sectors, the beneficial aspects of nanosensors have been exploited in healthcare systems to utilize their applications in diagnosing, treating, and preventing diseases. Hence, in this review, we have presented an overview of the disease-prognostic applications of nanosensors in chronic diseases through a detailed literature analysis. We focused on the advances in various nanosensors in the field of major diseases such as cancer, cardiovascular diseases, diabetes mellitus, and neurodegenerative diseases along with other prevalent diseases. This review demonstrates various categories of nanosensors with different nanoparticle compositions and detection methods suitable for specific diagnostic applications in clinical settings. The chemical properties of different nanoparticles provide unique characteristics to each nanosensors for their specific applications. This will aid the detection of potential biomarkers or pathological conditions that correlate with the early detection of various diseases. The potential challenges and possible recommendations of the applications of nanosensors for disease diagnosis are also discussed. The consolidated information present in the review will help to better understand the disease-prognostic potentials of nanosensors, which can be utilized to explore new avenues in improved therapeutic interventions and treatment modalities.